We are delighted to announce the two-day Up-to-Date Hepatology Course 2014, organized by the Romanian Society of Gastroenterology and Hepatology (SRGH) – the Hepatology Focus Group and Center for Digestive Diseases and Liver Transplantation at Fundeni Clinical Institute Bucharest, that will take place in Bucharest, between April 25th – 26th, 2014.
The course is addressed to all gastroenterologists interested to share their knowledge and personal experience in the field of hepatology. Top European and Romanian experts will provide an overview of the current status, define potential hurdles and suggest strategies for improving care in patients with viral hepatitis and liver cirrhosis. Continuing the recent initiative of Prof. Markus Peck-Radosavljevic, EASL Secretary General, a group of Eastern European experts will debate specific problems of managing patients with liver diseases in countries with limited health care resources.
This is an exciting time for physicians treating patients with chronic hepatitis C. Triple therapy using protease inhibitors, Peg-interferon and Ribavirin significantly increased the efficacy, becoming standard-of-care in hepatitis C patients in many countries. Unfortunately this isn’t the case in Romania, despite the fact that chronic hepatitis C is a major health problem in our country. At the same time, the new and exciting era of interferon-free therapy – simpler, shorter, more effective and better tolerated – is already on horizons. It is anticipated that the accelerated drug development and approval of „new waves” of therapy will lead to regimen changes almost every 3 months, giving the chance of cure to more than 90% of treated patients.
Practical applications of current knowledge, management of real-life patients and specific problems such as access to therapy, who to treat, when to treat and how to treat, and how to make the new treatments available in countries with limited health care resources will be addressed during plenary sessions and interactive break-out sessions with experts.
We will focus as well on hepatitis B and D, discussing the current therapeutic options, the long-term outcome of chronically infected subjects, response assessment and monitoring and management of special populations.
Cirrhosis is the final pathway for any chronic liver disease and an important cause of morbidity and mortality in Romania and worldwide. In the cirrhosis day of the course we will take the audience on a tour of the most challenging complications of the disease. We will discuss the recent advances and the current evidence-based strategies to prevent the risk or treat patients with cirrhosis and its specific complications.
Finally, Bucharest, a vibrant and cosmopolitan capital has much to offer you, bathed in the spring light of April and full of shops, restaurants and cultural attractions.
Official language of the course: English
Looking forward to welcoming all of you in Bucharest at the end of April,
Assoc. Prof. Liana Gheorghe
Prof. Mircea Grigorescu
Prof. Ioan Sporea